In a feature article appearing in the December issue of The Journal of Pain, the American Pain Society presents its Pain Research Agenda for the 21st Century, which it describes as identifying promising but underfunded approaches to develop new treatments and to help make currently used pain medications safer and more effective. Co-author, former APS President, and longtime PAINWeek faculty member Roger Fillingim, PhD, stated “Our work in developing the pain research agenda showed that even the most optimistic estimates indicate that pain research is woefully underfunded relative to its prevalence, disease burden and economic toll.”
The APS describes the Pain Research Agenda as a goal-oriented approach emphasizing important outcomes that must be achieved to meaningfully advance pain treatment. It notes that pain research expenditures at the National Institutes for Health (NIH) account for just 1 percent of the NIH research budget or $4 per affected individual, compared to cancer and HIV for which $431 and $2,562, respectively, are spent per affected person. Read a news story about the recommendations here. The journal abstract, with additional link to the full article, may be accessed here.